Skip to main content
. Author manuscript; available in PMC: 2019 Mar 27.
Published in final edited form as: Breast Cancer Res Treat. 2017 Sep 6;167(1):195–203. doi: 10.1007/s10549-017-4432-0

Fig. 3.

Fig. 3

Expected annual savings for specified strategies relative to current policy requirements for second opinion as base case assumptions are varied. Bars reflect the lower and upper bound estimates (1) Title of Y axis (‘‘Relative to if a second opinion was required by policy’’; and on X Axis: (2) Basecase Analyses (‘‘Based on 790,500 women undergoing breast biopsies every year according to baseline care pathways (see Appendix)’’; and (3) More Intensive Treatment Pathways (‘‘Based on 790,500 women undergoing breast biopsies every year but with breast MRI and hormonal therapy used in the year following a breast diagnosis involving Atypia’’)